Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1996-11-19
|
| pubmed:abstractText |
Recent progresses made in the biology of acute promyelocytic leukemia and therapeutic improvements obtained in acute promyelocytic leukemia since the advent of all-trans retinoic acid have continued to generate a large number of publications on this disease in the past 12 months, which concern both its biological and therapeutic aspects.
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
1040-8746
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
8
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
3-12
|
| pubmed:dateRevised |
2005-11-16
|
| pubmed:meshHeading | |
| pubmed:year |
1996
|
| pubmed:articleTitle |
Biology and treatment of acute promyelocytic leukemia.
|
| pubmed:affiliation |
C.H.U., Lille, France.
|
| pubmed:publicationType |
Journal Article,
Review
|